Small Biotech Cortexyme Briefly Doubles in Red-Hot Trading Debut

(Bloomberg) -- Lingering doubts about a trade deal between the U.S. and China failed to dampen investor enthusiasm or the sizzling debut of freshly-minted biopharmaceutical Cortexyme Inc..
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.